Surgery Partners (NASDAQ:SGRY) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Thursday.
Other equities research analysts also recently issued reports about the company. Zacks Investment Research upgraded Surgery Partners from a “hold” rating to a “buy” rating and set a $16.00 target price on the stock in a report on Wednesday. ValuEngine upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, June 21st. Leerink Swann assumed coverage on Surgery Partners in a research note on Tuesday, August 7th. They set an “outperform” rating and a $20.00 price objective for the company. Bank of America upgraded Surgery Partners from a “neutral” rating to a “buy” rating in a research note on Tuesday, September 18th. Finally, Stifel Nicolaus upgraded Surgery Partners from a “sell” rating to a “hold” rating and set a $15.00 price objective for the company in a research note on Thursday, June 28th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $18.86.
Shares of NASDAQ:SGRY opened at $14.81 on Thursday. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.44 and a current ratio of 1.59. Surgery Partners has a one year low of $7.10 and a one year high of $19.95.
In other Surgery Partners news, insider Brandan Lingle sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 28th. The stock was sold at an average price of $18.15, for a total transaction of $181,500.00. Following the completion of the sale, the insider now owns 20,393 shares in the company, valued at approximately $370,132.95. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 8.20% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently modified their holdings of the company. NN Investment Partners Holdings N.V. grew its position in shares of Surgery Partners by 4.8% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 5,523,801 shares of the company’s stock worth $82,305,000 after acquiring an additional 250,704 shares in the last quarter. BlackRock Inc. grew its position in shares of Surgery Partners by 3.6% in the 2nd quarter. BlackRock Inc. now owns 1,338,176 shares of the company’s stock worth $19,939,000 after acquiring an additional 46,111 shares in the last quarter. Redmile Group LLC acquired a new position in shares of Surgery Partners in the 2nd quarter worth approximately $9,257,000. Dimensional Fund Advisors LP grew its position in shares of Surgery Partners by 5.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 571,218 shares of the company’s stock worth $8,512,000 after acquiring an additional 29,643 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in shares of Surgery Partners in the 1st quarter worth approximately $6,097,000. Institutional investors own 97.53% of the company’s stock.
Surgery Partners Company Profile
Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Featured Article: Stock Symbols and CUSIP Explained
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.